Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Bright spots in tackling AMRs, but drug-resistance outpaces pharma industry efforts: Report
Drug resistance is outpacing industry-wide efforts, says Netherlands-based Access to Medicine Foundation in its latest Antimicrobial Resistance (AMR) Benchmark report, even as it identified seven innovative late-stage projects that targetted…
Here is Why JPMorgan is Overweight on Apellis Pharma (APLS)
Apellis Pharmaceuticals Inc. (NASDAQ: APLS) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 5, Anupam Rama from JPMorgan increased the price target on Apellis Pharmaceuticals Inc. (NASDAQ:APLS) from $36 to…
BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 2, Wedbush analyst Laura Chico increased the firm's price target on BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) to…
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 20, Bank of America Securities lowered the price target on Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) from $570…
AP Shills For Big Pharma Antidepressants With 'Bewildering' Hit Piece
Check this out... The Trump FDA's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who strongly believes the agency should add new warnings about antidepressants and pregnancy risks. So what does the Associated…
Nifty holds 24,200 at midday; Auto and Pharma lead gains as IT drags
Markets extended the morning's recovery into the afternoon session on Tuesday, with the benchmark indices trading higher around midday, building on the gap-up open triggered by easing geopolitical tensions and a sharp retreat in global crude oil…
BridgeBio Pharma (NASDAQ:BBIO) Trading Up 9.3% - Should You Buy?
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) shot up 9.3% on Tuesday. The company traded as high as $70.49 and last traded at $71.7590. 1,265,413 shares traded hands during mid-day trading, a decline of 60% from the average…
BridgeBio Pharma (NASDAQ:BBIO) Now Covered by Analysts at William Blair
Investment analysts at William Blair started coverage on shares of BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) in a research note issued to investors on Tuesday. The firm set an 'outperform' rating on the stock. BridgeBio's Volatile Week Puts…
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $3,165,350.10 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 104,467 shares of NewAmsterdam Pharma stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $30.30…
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells 94,124 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 94,124 shares of the company's stock in a transaction on Friday, March 6th. The stock was sold at an average price of $30.32, for a total…
BMO Hosts Third Annual Metabolic Health Summit on the Future of the GLP-1+ Market
Healthcare industry experts and leaders to convene March 24 at the 2026 BMO Metabolic Health Summit (formerly the Obesity Summit) to examine outlook and trends in metabolic disease and drug therapies NEW YORK, March 10, 2026 /CNW/ - BMO Capital…
Johannes Jacob Piete Kastelein Sells 101,409 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 101,409 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $30.29, for a…
Second morning-after pill now available over the counter in Japan
Alinamin Pharmaceutical on Monday began selling emergency contraceptives to help protect against unintended pregnancies, the second such product to become available over the counter (OTC) in Japan. Lesoeru 72, which is priced at ¥6,930 ($44)…
Pipeline of new drugs to fight superbugs is 'worryingly thin', experts warn
The pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have warned, predicting the annual number of deaths linked to drug-resistant infections globally will double…
Supreme Novices' Hurdle odds: Latest prices & betting guide
The Supreme Novices' Hurdle is the traditional opening race of the Cheltenham Festival and is one of the most prestigious novice hurdles in National Hunt racing, with famed winners including Constitution Hill and 2025 victor Kopek Des Bordes. This…
Receive a Daily briefing on Pharma Industry News
Get Started